SCHEMBL1012168

SCHEMBL1012168

CC12C=CC(OC(=O)O)(CC1)CC2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11723435 0.70
SCHEMBL9606 0.67 FFAR3 (0.40) FFAR3
SCHEMBL3670104 0.64
Hydrochloric Acid SCHEMBL4398568 0.62
SCHEMBL5185822 0.61 CYP3A4 (0.31)
SCHEMBL12986569 0.61 CYP19A1 (0.41) FFAR3
SCHEMBL21230083 0.60
SCHEMBL1655866 0.60 FFAR3 (0.32) FFAR3
SCHEMBL6581060 0.59 FFAR3 (0.35) FFAR3
SCHEMBL9804280 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2526771-B1 Inhibitors of bruton's tyrosine kinase PHARMACYCLICS LLC (US) 2016-11-30 EP claimed
EP-2511257-B1 Composition comprising an alpha ketoamide compound as cysteine protease inhibitor VIROBAY INC (US) 2015-06-17 EP claimed
EP-1656372-B1 2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR USE IN THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES RIGEL PHARMACEUTICALS INC (US) 2013-04-10 EP claimed
EP-1824489-B1 STEREOISOMERICALLY ENRICHED 3-AMINOCARBONYL BICYCLOHEPTENE PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS INC (US) 2011-01-05 EP claimed